Sima Jeha

Director, Eastern Mediterranean Region, St. Jude Global · St Jude Children's Research Hospital

Credentials: · ·

History

Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
Principal investigator · Terminated · Phase 2
St. Jude Children's Research Hospital
2019–2025
Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma
Principal investigator · Terminated · Phase 2
St. Jude Children's Research Hospital
2016–2018
Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
Principal investigator · Active not recruiting · Phase 1, Phase 2
St. Jude Children's Research Hospital
2016–2031
Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies
Principal investigator · Completed · Phase 1
St. Jude Children's Research Hospital
2013–2016